Search research articles
Contact Us
Filters
Showing results (31-40 of 139) with videos related to
Page
of 14
Sort By:
Molecular Pharmacology
|
December 25, 2007
Distinctions between dopamine transporter antagonists could be just around the bend
L Keith Henry, Randy D Blakely
Minnesota Medicine
|
November 18, 2009
Peering into the future: searching for answers to old and new questions about HIV/AIDS
W Keith Henry, Ogechika K Alozie, Shulamith Bonham
Minnesota Medicine
|
November 18, 2009
The epidemiology of HIV/AIDS in Minnesota: current trends
Shulamith Bonham, Ogechika K Alozie, W Keith Henry
Minnesota Medicine
|
November 18, 2009
Management of HIV: a swing back to the future
Ogechika K Alozie, Shulamith Bonham, W Keith Henry
JAMA
|
September 28, 2006
Explaining, predicting, and treating HIV-associated CD4 cell loss: after 25 years still a puzzle
W Keith Henry, Pablo Tebas, H Clifford Lane
Molecular Interventions
|
January 18, 2008
Bound to be different: neurotransmitter transporters meet their bacterial cousins
L Keith Henry, Jens Meiler, Randy D Blakely
Current Opinion in HIV and AIDS
|
June 18, 2009
The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms
Jason V Baker, W Keith Henry, James D Neaton
The Journal of Biological Chemistry
|
February 18, 2010
Transmembrane domain 6 of the human serotonin transporter contributes to an aqueously accessible binding pocket for serotonin and the psychostimulant 3,4-methylene dioxymethamphetamine
Julie R Field, L Keith Henry, Randy D Blakely
Neuron
|
March 18, 2006
Getting the message across: a recent transporter structure shows the way
L Keith Henry, Louis J DeFelice, Randy D Blakely
AIDS Clinical Care
|
January 4, 2006
Antiretroviral rounds. A communication conundrum
Keith Henry, John A Bartlett, Erna Kojic, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 139) with videos related to
Sort By:
Page
of 14
Molecular Pharmacology
|
December 25, 2007
Distinctions between dopamine transporter antagonists could be just around the bend
L Keith Henry, Randy D Blakely
Minnesota Medicine
|
November 18, 2009
Peering into the future: searching for answers to old and new questions about HIV/AIDS
W Keith Henry, Ogechika K Alozie, Shulamith Bonham
Minnesota Medicine
|
November 18, 2009
The epidemiology of HIV/AIDS in Minnesota: current trends
Shulamith Bonham, Ogechika K Alozie, W Keith Henry
Minnesota Medicine
|
November 18, 2009
Management of HIV: a swing back to the future
Ogechika K Alozie, Shulamith Bonham, W Keith Henry
JAMA
|
September 28, 2006
Explaining, predicting, and treating HIV-associated CD4 cell loss: after 25 years still a puzzle
W Keith Henry, Pablo Tebas, H Clifford Lane
Molecular Interventions
|
January 18, 2008
Bound to be different: neurotransmitter transporters meet their bacterial cousins
L Keith Henry, Jens Meiler, Randy D Blakely
Current Opinion in HIV and AIDS
|
June 18, 2009
The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms
Jason V Baker, W Keith Henry, James D Neaton
The Journal of Biological Chemistry
|
February 18, 2010
Transmembrane domain 6 of the human serotonin transporter contributes to an aqueously accessible binding pocket for serotonin and the psychostimulant 3,4-methylene dioxymethamphetamine
Julie R Field, L Keith Henry, Randy D Blakely
Neuron
|
March 18, 2006
Getting the message across: a recent transporter structure shows the way
L Keith Henry, Louis J DeFelice, Randy D Blakely
AIDS Clinical Care
|
January 4, 2006
Antiretroviral rounds. A communication conundrum
Keith Henry, John A Bartlett, Erna Kojic, et al.
Page
of 14